[1]
«Medicines for reduced ejection fraction heart failure in Central region of Portugal’s primary care: a 2022 observational study», Rev Port Med Geral Fam, vol. 40, n. 4, pp. 339–46, Set. 2024, doi: 10.32385/rpmgf.v40i4.13770.